рак крови лейкемия

In research AGO-GINECO authors have estimated expediency of addition антрациклинов to a combination карбоплатин паклитаксел. Inclusion эпирубицина has strengthened toxicity of a combination, but has not improved results of therapy [10]. In research SCOTROC comparison available today in our disposal таксанов is made: паклитаксела and доцетаксела [11]. Both preparations in a combination with карбоплатином have shown identical frequency of objective effects and time before progressing. The combination карбоплатин-паклитаксел possessed more expressed нейротоксичностью while карбоплатин-доцетаксел caused development нейтропении is more often. Подробнее...

In communication{connection} with obviously not radical character циторедуктивной to operation by all sick cancer яичника IC-IV stages show carrying out of chemotherapy. Last years there is an intensive search of the most effective combination for carrying out of the first line of chemotherapy. In table 2 results of the most important рандомизированных the researches published in the literature or reported in a preliminary kind at the international congresses and conferences are resulted. At the analysis of results of treatment the essential increase in life expectancy of patients with the widespread cancer яичников is evident. If in the end 80-Х--the beginning of 90th years average life expectancy made 18-24 months in the majority of the resulted researches this parameter has increased till 30-38 months. Подробнее...